Unusual 11 Mid-Day Movers 12/14: MTXX, CTDC, EMS, CYPB, GXDX, NTWK Higher; CAPS, EONC, INHX, CSPI, BBY Lower
Matrixx Initiatives (Nasdaq: MTXX) 56.1% HIGHER; announced that it has entered into an agreement to be acquired by investment funds managed by H.I.G. Capital, LLC for $8 per share, representing a 56.3% premium to Matrixx's closing price on Dec.
13. The deal is being valued at about $75.2 million.
Capstone Therapeutics (Nasdaq: CAPS) 51.4% LOWER; announced twelve-month results for two Phase 2a of AZX100 in keloid scarring as well as seven-month interim results of its ongoing AZX100 Phase 2a pilot clinical trial in surgical (trocar site) scarring.
Click here to see the full report.
eOn Communications Corp. (Nasdaq: EONC) 28.6% LOWER; reports Q1 EPS of $0.09, versus $0.14 reported for the same period a year ago. Revenue for the quarter was $5.86 million, compared to $4.53 million in Q110.
China Technology Development Group Corporation (Nasdaq: CTDC) 26.1% HIGHER; announces the appointment of Liao Lin-Hsiang as the Chief Operating Officer and Bruno Diaz Herrera as Chief Technology Officer.
Inhibitex (Nasdaq: INHX) 23.2% LOWER; reports "promising" top-line results from a Phase II Trial of FV-100 for the treatment of shingles. Click here to see the full report.
CSP Inc. (Nasdaq: CSPI) 20.0% LOWER; reports Q4 EPS of $0.01, versus ($1.02) reported for the same period a year ago.
Revenue for the quarter was $23.9 million, compared to $18.1 million in Q309.
Emergency Medical (NYSE: EMS) 18.4% HIGHER; DealReporter story suggesting that the company has hired Goldman Sachs in order to evaluate a sale process.
Cypress Bioscience, Inc. (Nasdaq: CYPB) 18.4% HIGHER; announced that their Board has rejected the $6.00 per outstanding common share takeover bid by Ramius.
Genoptix (Nasdaq: GXDX) 16.4% HIGHER; shares are on the moving in after-hours trading following a Bloomberg report which rumors that the company has hired Barclays in order look for strategic buyers.
Best Buy Co., Inc. (NYSE: BBY) 15.4% LOWER; reports Q3 EPS of $0.54, vs. the analyst estimate of $0.61. Revenue for the quarter came in at $11.89 billion, versus the consensus estimate of $12.47 billion. Comps down 3.3%. Lowers its FY11 EPS from $3.55-$3.70 to $3.20-$3.40, vs. the consensus of $3.59.
NetSol Technologies Inc. (Nasdaq: NTWK) 12.3% HIGHER; disclosed that their CEO, Najeeb Ghauri, purchased 278,846 common shares on December 10, 2010. Specifically, Ghauri acquired 125,000 shares on 12/10 at $1.49 and 153,846 shares on 12/10 at $1.51, bringing his stake to 1,728,546 shares.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
13. The deal is being valued at about $75.2 million.
Capstone Therapeutics (Nasdaq: CAPS) 51.4% LOWER; announced twelve-month results for two Phase 2a of AZX100 in keloid scarring as well as seven-month interim results of its ongoing AZX100 Phase 2a pilot clinical trial in surgical (trocar site) scarring.
Click here to see the full report.
eOn Communications Corp. (Nasdaq: EONC) 28.6% LOWER; reports Q1 EPS of $0.09, versus $0.14 reported for the same period a year ago. Revenue for the quarter was $5.86 million, compared to $4.53 million in Q110.
China Technology Development Group Corporation (Nasdaq: CTDC) 26.1% HIGHER; announces the appointment of Liao Lin-Hsiang as the Chief Operating Officer and Bruno Diaz Herrera as Chief Technology Officer.
Inhibitex (Nasdaq: INHX) 23.2% LOWER; reports "promising" top-line results from a Phase II Trial of FV-100 for the treatment of shingles. Click here to see the full report.
CSP Inc. (Nasdaq: CSPI) 20.0% LOWER; reports Q4 EPS of $0.01, versus ($1.02) reported for the same period a year ago.
Revenue for the quarter was $23.9 million, compared to $18.1 million in Q309.
Emergency Medical (NYSE: EMS) 18.4% HIGHER; DealReporter story suggesting that the company has hired Goldman Sachs in order to evaluate a sale process.
Cypress Bioscience, Inc. (Nasdaq: CYPB) 18.4% HIGHER; announced that their Board has rejected the $6.00 per outstanding common share takeover bid by Ramius.
Genoptix (Nasdaq: GXDX) 16.4% HIGHER; shares are on the moving in after-hours trading following a Bloomberg report which rumors that the company has hired Barclays in order look for strategic buyers.
Best Buy Co., Inc. (NYSE: BBY) 15.4% LOWER; reports Q3 EPS of $0.54, vs. the analyst estimate of $0.61. Revenue for the quarter came in at $11.89 billion, versus the consensus estimate of $12.47 billion. Comps down 3.3%. Lowers its FY11 EPS from $3.55-$3.70 to $3.20-$3.40, vs. the consensus of $3.59.
NetSol Technologies Inc. (Nasdaq: NTWK) 12.3% HIGHER; disclosed that their CEO, Najeeb Ghauri, purchased 278,846 common shares on December 10, 2010. Specifically, Ghauri acquired 125,000 shares on 12/10 at $1.49 and 153,846 shares on 12/10 at $1.51, bringing his stake to 1,728,546 shares.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
You May Also Be Interested In
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Ramius Capital, Barclays, Unusual 11 Mid-Day Movers, Matrixx Initiatives/H.I.G. CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
